The genetic and biochemical basis of Omenn syndrome

Immunological Reviews

Volumn 178, Issue , 2000, Pages 64-74

  Santagata, Sandro ^a   Villa, Anna ^b   Sobacchi, Cristina ^c   Cortes, Patricia ^a   Vezzoni, Paolo ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Ist Tecnologie Biomediche Avanzate   (Italy)

^c Immunobiology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL RECESSIVE DISORDER; BONE MARROW TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; ERYTHRODERMA; GENE MUTATION; GENE REARRANGEMENT; GENE THERAPY; GENETIC RECOMBINATION; HEPATOSPLENOMEGALY; HUMAN; HYPEREOSINOPHILIA; HYPERIMMUNOGLOBULINEMIA E; IMMUNOGENETICS; LYMPHADENOPATHY; MISSENSE MUTATION; OMENN SYNDROME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; REVIEW; SYNDROME; THYMUS;

EID: 0034501028     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17818.x     Document Type: Review

References (119)

1. Familial reticuloendotheliosis with eosinophilia
2. RAG mutations in human B cell-negative SCID
3. Increased radiosensitivity of granulocyte macrophage colony-forming units and skin fibroblasts in human autosomal recessive severe combined immunodeficiency
4. Three-dimensional clustering of human RAG2 gene mutations in severe combined immune deficiency
5. Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D)J recombination and result in primary immunodeficiencies
6. N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements
7. The RAG1/RAG2 complex constitutes a 3′ flap endonuclease: Implications for junctional diversity in V(D)J and transpositional recombination
8. Partial V(D)J recombination activity leads to Omenn syndrome
9. N-terminal RAG1 frameshift mutations in Omenn syndrome: Internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains
10. Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome)
11. T-cell receptor analysis in Omenn's syndrome: Evidence for defects in gene rearrangement and assembly
12. + T lymphocytes in Omenn syndrome
13. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome
14. Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome
15. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders
16. V(D)J recombination defects in lymphocytes due to RAG mutations: A severe immunodeficiency with a spectrum of clinical presentations
17. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation
18. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency
19. In vitro cell death of activated lymphocytes in Omenn's syndrome
20. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2-mediated condition
21. T helper type 2-like cells and therapeutic effects of interferon-γ in combined immunodeficiency with hypereosinophilia (Omenn's syndrome)
22. Somatic generation of antibody diversity
23. The RAG proteins and V(D)J recombination: Complexes, ends, and transposition
24. P nucleotide insertions and the resolution of hairpin DNA structures in mammalian cells
25. P nucleotides, hairpin DNA and V(D)J joining: Making the connection
26. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination
27. The V(D)J recombination activating gene, RAG-1
28. Evolution of antigen binding receptors
29. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system
30. DNA transposition by the RAG1 and RAG2 proteins: A possible source of oncogenic translocations
31. New insights into V(D)J recombination and its role in the evolution of the immune system
32. RAG1/2-mediated resolution of transposition intermediates: Two pathways and possible consequences
33. Essential residues in V(D)J recombination signals
34. V(D)J recombination: A functional definition of the joining signals
35. Conservation of sequence in recombination signal sequence spacers
36. The complete 685-kilobase DNA sequence of the human β T cell receptor locus
37. H
38. Initiation of V(D)J recombination in vitro obeying the 12/23 rule
39. Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes
40. The 12/23 rule is enforced at the cleavage step of V(D)J recombination in vivo
41. Recombination signal sequences restrict chromosomal V(D)J recombination beyond the 12/23 rule
42. Mechanisms that direct ordered assembly of T cell receptor beta locus V, D, and J gene segments
43. Double-strand breaks associated with V(D)J recombination at the TCR δ locus in murine thymocytes
44. Characterization of broken DNA molecules associated with V(D)J recombination
45. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′ phosphorylated, RAG-dependent, and cell cycle regulated
46. A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage
47. RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination
48. The homeodomain region of Rag- 1 reveals the parallel mechanisms of bacterial and V(D)J recombination
49. Distinct roles of RAG1 and RAG2 in binding the V(D)J recombination signal sequences
50. Detection of RAG protein-V(D)J recombination signal interactions near the site of DNA cleavage by UV cross-linking
51. A dimer of the lymphoid protein RAG1 recognizes the recombination signal sequence and the complex stably incorporates the high mobility group protein HMG2
52. + cofactors at the initial stages of V(D)J recombination
53. V(D)J recombination signal recognition: Distinct, overlapping DNA-protein contacts in complexes containing RAG1 with and without RAG2
54. Identification of two catalytic residues in RAG1 that define a single active site within the RAG1/RAG2 protein complex
55. Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase
56. Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG 1 critical for both cleavage steps of V(D)J recombination
57. DNA transposition: From a black box to a color monitor
58. A general two-metal-ion mechanism for catalytic RNA
59. RAG-2 promotes heptamer occupancy by RAG-1 in the assembly of a V(D)J initiation complex
60. Assembly of a 12/23 paired signal complex: A critical control point in V(D)J recombination
61. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps
62. Hairpin coding end opening is mediated by RAG1 and RAG2 proteins
63. DNA hairpin opening mediated by the RAG1 and RAG2 proteins
64. The 3′ to 5′ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks
65. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex
66. The FEN-1 family of structure-specific nucleases in eukaryotic DNA replication, recombination and repair
67. Coding joint formation in a cell-free V(D)J recombination system
68. Cell-free V(D)J recombination
69. V(D)J recombination: In vitro coding joint formation
70. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination
71. In vitro V(D)J recombination: Signal joint formation
72. Antigen receptor gene rearrangement
73. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient
74. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV
75. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis
76. Regions of RAG 1 protein critical for V(D)J recombination
77. Expression and V(D)] recombination activity of mutated RAG-1 proteins
78. Dispensable sequence motifs in the RAG-1 and RAG-2 genes for plasmid V(D)J recombination
79. Definition of minimal domains of interaction within the recombination activating genes 1 and 2 recombinase complex
80. Analysis of regions of RAG-2 important for V(D)J recombination
81. Definition of a core region of RAG-2 that is functional in V(D)J recombination
82. Dual role of RAG2 in V(D)J recombination: Catalysis and regulation of ordered Ig gene assembly
83. Roles of the "dispensable" portions of RAG-1 and RAG-2 in V(D)J recombination
84. Primordial emergence of the recombination activating gene 1 (RAG1): Sequence of the complete shark gene indicates homology to microbial integrases
85. Crystal structure of the RAG1 dimerization domain reveals multiple zinc-binding motifs including a novel zinc binuclear cluster
86. A zinc-binding domain involved in the dimerization of RAG1
87. RAG-1 interacts with the repeated amino acid motif of the human homologue of the yeast protein SRP1
88. Rch1, a protein that specifically interacts with the RAG-1 recombination-activating protein
89. Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2
90. A basic motif in the N-terminal region of RAG1 enhances V(D)J recombination activity
91. - B cells reveals a requirement for novel elements in the N-terminus of RAG-1
92. The V(D)J recombination activating protein RAG2 consists of a six-bladed propeller and a PHD fingerlike domain, as revealed by sequence analysis
93. The PHD finger: Implications for chromatin-mediated transcriptional regulation
94. KAP-1, a novel corepressor for the highly conserved KRAB repression domain
95. Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain
96. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
97. Positional cloning of the APECED gene
98. ClpX protein of Escherichia coli activates bacteriophage Mu transposase in the strand transfer complex for initiation of Mu DNA synthesis
99. Disassembly of the Mu transposase tetramer by the ClpX chaperone
100. Molecular cloning and characterization of a mouse homolog of bacterial ClpX, a novel mammalian class II member of the Hsp 100/Clp chaperone family
101. RAG-1-deficient mice have no mature B and T lymphocytes
102. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
103. Severe combined immunodeficiencies
104. Evidence for defects in V(D)J rearrangements in patients with severe combined immunodeficiency
105. H locus
106. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy
107. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination
108. The kelch repeat superfamily of proteins: Propellers of cell function
109. Novel thioether bond revealed by a 1.7 Å crystal structure of galactose oxidase
110. Prenatal diagnosis of severe combined immunodeficiency
111. Antenatal diagnosis of severe combined immunodeficiency from fetal cord blood
112. Prenatal testing for inherited immune deficiencies by fetal blood sampling
113. Prenatal diagnosis
114. Prenatal diagnosis of RAG-deficient Omenn syndrome
115. Thirty years of borne marrow transplantation for severe combined immunodeficiency
116. Treatment of Omenn syndrome by bone marrow transplantation
117. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI)
118. Sorrentino BP Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer
119. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease